-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Krystal Biotech, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2017 to 2024.
- Krystal Biotech, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $2.59M.
- Krystal Biotech, Inc. annual Income Tax Expense (Benefit) for 2024 was $6.2M, a 215% increase from 2023.
- Krystal Biotech, Inc. annual Income Tax Expense (Benefit) for 2023 was $1.97M.
- Krystal Biotech, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)